Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole and Cabergoline for Ovulation Induction in PCOS
NCT07168837Completed
- Sponsor
- Al-Azhar University
- Start
- Jan 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cabergoline in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Al-Azhar University. Primary endpoint: Identification of Ovulation at 1 week. Started Jan 2023; status: completed.
02
Drugs
cabergoline
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT07168837.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07168837.